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The purpose of the present investigation is to assess, for the first time, the antidiabetic, antihyperlipidemic 
and antioxidant activities of Lycium europaeum extract in alloxan-induced diabetic rats. Diabetes was 
induced in adult male Wistar rats via a single subcutaneous alloxan injection (120 mg/kg). Lycium 
europaeum aqueous extract was orally administered at a dose of 20 mg/kg for 28 consecutive days. 
Serum concentrations of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density 
lipoprotein cholesterol (HDL-C) and triglycerides (TG) were assayed at the end of the experimental 
period in all investigated groups. Antioxidant enzymes such as glutathione peroxidase (GPx), catalase 
(CAT) and superoxide dismutase (SOD) were sought in the serum and pancreas. Lycium europaeum 
extract significantly increased HDL-C and reduced blood glucose, TC, LDL-C and TG as compared 
to the alloxan-control group. Lycium europaeum extract was also efficient in reducing oxidative stress 
in diabetic rats by increasing SOD, CAT and GPx activities both in the pancreas and the plasma of 
the animals. Moreover, Lycium europaeum extract contained considerable levels of polyphenols and 
flavonoids. It also exhibited an important antioxidant capacity and a remarkable ability to quench DPPH 
radicals and reduce irons. The obtained results highlight potentially relevant health beneficial effects 
of Lycium europaeum extract, reversing hyperglycemic, hyperlipidemic and oxidative stress effects 
in rats with alloxan-induced diabetes. Therefore, it may be considered as a promising alternative or 
complementary agent to diabetes treatment. 
Keywords: Lycium europaeum/extract/antihyperglycemia. Lycium europaeum/extract/antioxidant 
activity. Lycium europaeum/extract/antihyperlipidemia.
INTRODUCTION
Diabetes mellitus (DM) is a chronic endocrine 
metabolic disorder that poses a major public health 
problem around the world. The World Health Organization 
(WHO) predicted it would be the 7th leading cause of 
death by 2030 (WHO, 2011). The progressive spreading 
of diabetes in both developed and developing countries 
has challenged scientists to conduct further investigation 
seeking potent therapeutic agents from natural sources 
for a more efficient use in the treatment and management 
of diabetes (Gupta et al., 2012). DM is defined as a 
degenerative and chronic disease induced when the 
pancreas does not produce sufficient insulin, or when 
the body cannot effectively process this hormine (WHO, 
2006). Diabetes frequently leads to serious complications 
(Deshpande, Harris-Hayes, Schootman, 2008), namely 
nephropathy, neuropathy and retinopathy (Winkler et al., 
2010), which can be delayed and reduced by maintaining 
tight glycemic control. Additionally, glucose homeostasis 
disorders also involve abnormalities in lipid metabolism 
characterized by a reduced cholesterol rate in high-density 
lipoprotein and increased triglyceride, total cholesterol 
and cholesterol rates of low-density lipoprotein (Capewell 
et al., 2010). In fact, hyperlipidemia poses a major risk 
for the premature development of atherosclerosis and 
cardiovascular complications (Goldstein et al., 1973). 
In the past few decades, increasing evidence has 
connected oxidative stress to a variety of pathological 
diseases, including DM (El Faramawy, Rizk, 2011). iD
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Over time, convincing evidence has established the role 
of free radicals and oxidative stress in the pathogenesis 
and development of complications emanating from 
DM. The possible sources of oxidative stress in diabetes 
might include glucose auto-oxidation, redox balance 
shifts, decreased tissue concentrations of low molecular 
weight antioxidants (vitamin E) and impaired activities 
of antioxidant defense enzymes as superoxyde dismutase 
and catalase (Haskins, BradLey, 2003). 
An effective management of diabetes requires 
combined multiple therapeutic approaches: exercise and 
diet. In fact, synthetic drugs are effectual in DM treatment 
but restricted by their limited action, pharmacokinetic 
properties, secondary failure rates and numerous side 
effects including hypoglycemia, damage to liver, lactic 
acidosis, diarrhea, abdominal pain, weight loss and loss 
of appetite (Dey, Attele, Yuan, 2002). Hence, safer and 
more effective antidiabetic drugs are deemed requisite. 
Nowadays, several people around the world are using 
natural remedies solely or in combination with their 
hypoglycemic drugs to manage their diabetes. As plants 
are safe and cost-effective (Punithavathi et al., 2011; Sefi 
et al., 2010), various herbal medicines and medicinal 
plants have been traditionally used for the control, 
management and/or treatment of diabetes (Ramachandran, 
Rajasekaran, Manisenthilkumar, 2012). To date, over 800 
species have been investigated and their hypoglycemic 
effect reported (El-Abhar, Schaalan, 2014). Medicinal 
plants with antioxidant activity have been scrutinized for 
their hypoglycemic activities. Consequently, medicinal 
plant screening for therapeutic schemes is important in 
drug development, as plants may possess hypoglycemic, 
hypolipidemic and antioxidant activities, which may be 
effective in the treatment of this chronic disease (Tiwari, 
Rao, 2002). 
Boxthorn (Lycium europaeum) belongs to the 
Solanaceae family and occurs spontaneously around the 
Mediterranean basin with three other species, namely L. 
barbarum, L. shawii, and L. chinense. These species have 
widely been used in traditional medicine. In fact, the L. 
shawii root decoction is widely renowned to treat mouth 
sores, cough, high blood pressure and diabetes. Fruit of 
this plant is also consumed for its antioxidant and other 
beneficial properties (Said et al., 2002). Concerning L. 
barbarum, several studies have indicated its benefits 
on aging, neuroprotection, general well-being, fatigue/
endurance, metabolism/energy expenditure, glaucoma, 
immunomodulation, antitumor activity and cytoprotection 
(Amagase, Farnsworth, 2011) as well as hypoglycemic and 
antioxidant effects in cell or animal experiments (Jin et al., 
2013; Zhu et al., 2013; Zhao et al., 2009; Luo et al., 2004). 
In Tunisia, the L. europaeum species is widely 
used as a functional food and as a medicinal herb in the 
treatment of diabetes without an adequate knowledge base. 
However, to the best of our knowledge, the anti-diabetic 
effect of L. europaeum leaves has not been explored. For 
this reason, the goal of the present study was to investigate 
the anti-diabetic, antihyperlipidemic and antioxidant 
activities of boxthorn leaves in alloxan-induced diabetic 
rats.
MATERIAL AND METHODS
Plant material 
Fresh and mature whole boxthorn plants were 
collected in December 2016 from Jdaida (35° 33’ 18” 
North, 9° 59’ 1” East of Tunis, Tunisia). Botanical 
identification was carried out and a voucher specimen 
AMP 561 was deposited at the faculty of Science, 
University of Tunis El Manar of Tunisia. Boxthorn leaves 
were washed with water, dried at room temperature in the 
dark and then ground to a fine powder in a Mettler AE 200 
(Dangoumau type) grinder. 
Preparation of plant extract
75 g of the powder was soaked in 1 l boiled water at 
100°C for 15 min for extraction (Ayiguli et al., 2007). The 
water extract was filtered with N°3 Whatmann Millipore 
filter paper and subjected to freeze drying yielding 
20.0 w/w of dry material that was stored in refrigerated 
amber glass containers. This procedure was repeated 
weekly throughout the study.
Total phenolic content
Total phenolic content of the aqueous extract 
from L. europaeum leaves was determined using the 
Folin-Ciocalteu reagent (Dewanto et al., 2002). An 
aliquot (0.125 mL) of a suitable diluted leaf extract 
(50-400 mg/mL) was added to 0.5 mL of deionized 
water and 0.125 mL of the Folin-Ciocalteu reagent. The 
mixture was shaken and allowed to stand for 6 min, 
before adding 1.25 mL of 7% Na2CO3 solution. The 
solution was then adjusted with deionised water to 
a final volume of 3 mL and mixed thoroughly. After 
incubation for 90 min at 23ºC, the absorbance versus 
prepared distilled water blank was read at 760 nm with 
an UV-Visible spectrophotometer. Total phenolic content 
of leaves was expressed as mg gallic acid equivalents 
per gram of dry weight (mg GAE/g DW) through the 
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calibration curve with gallic acid. The calibration curve 
range was 50-400 mg/mL (R2 = 0.99). All samples were 
analyzed in triplicate.
Total flavonoid content 
Total flavonoid content of the aqueous extract from L. 
europaeum leaves was determined by a colorimetric assay 
according to Dewanto et al. (2002). An aliquot (250 mL) of 
a suitable leaf extract (50-500 mg/mL) was mixed with 75 
mL NaNO2 (5%). After 6 min, 150 mL of 10% aluminium 
chloride was added and 5 min later, 500 mL of NaOH 
(1M) was added. Finally, the mixture was adjusted to 2.5 
mL with distilled water. The absorbance versus prepared 
distilled water blank was read at 510 nm with a UV-Visible 
spectrophotometer. Total flavonoid content of leaves was 
expressed as mg catechin equivalents per gram of dry 
weight (mg CE/g DW) through the calibration curve with 
catechin in the range of 50-500 mg/ mL. All samples were 
analyzed in triplicate.
Evaluation of antioxidant capacity
Total antioxidant capacity of aqueous extract from 
L. europaeum leaves was determined through the assay 
of the green Phosphate/ Mo5+ complex according to the 
method described by Prieto, Pineda and Aguilar (1999). 
An aliquot (0.2 mL) of sample extract was combined with 
2 mL of reagent solution (0.3 N Sulfuric acid. 28 mM 
sodium phosphate and 4 mM ammonium molybdate). 
Methanol (80%) was used instead of sample for the blank. 
The tubes were capped and incubated in a boiling water 
bath for 90 min. Then, samples were cooled to room 
temperature and the absorbance was read at 695 nm against 
blank. Antioxidant capacity was expressed as mg gallic 
acid equivalent per gram dry weight (mg GAE/g DW). All 
samples were analyzed in triplicate.
Scavenging ability on DPPH radical
The ability of the corresponding extracts to donate 
hydrogen atoms or electrons was measured from the 
bleaching of a purple colored methanol solution of 
1.1-diphenyl-2- picrylhydrazyl (DPPH), according to 
the method described by Hatano et al. (1988). 1 mL of 
various concentrations (1-100 µg/mL) of L. europaeum 
leaf extract was added to 250 µl of 0.2 mM DPPH 
radical solution in methanol. The mixture was shaken 
vigorously and allowed to stand for 30 min in the dark. The 
absorbance of the resulting solution was read at 517 nm 
and butylatedhydroxyl toluene (BHT) was used as positive 
control. Inhibition of DPPH radical was calculated as 
follows: 
DPPH scavenging effect (%) = ((Ac – AS) / Ac)) × 100
where Ac and AS are the absorbance at 30 min of the control 
and the sample, respectively. The anti-radical activity was 
expressed as IC50 (µg/mL), the extract dose required to 
cause a 50% decrease of the absorbance at 517 nm. A lower 
IC50 value corresponded to a higher antioxidant activity. 
All samples were analyzed in triplicate.
Iron reducing power
Iron reducing power was determined according to 
the method of Oyaizu (1986). 1 mL of sample extracts at 
different concentrations (30, 60, 90, 120 and 150 mg/mL) 
was mixed with 2.5 mL phosphate buffer (0.2 M, pH 6.6) 
and 2.5 mL potassium ferricyanide (1g/100 mL). After 
incubation at 50°C for 20 min, the mixture was added 
to 250 µl of thichloroacetic acid (10g/100 mL) and then 
centrifuged at 3500 r/min for 10 min. As soon as 400 µL 
supernatant was aliquoted into 400 µl FeCl3 (0.1 g/100 mL 
in distilled water), the timer was started. At 90 s, the 
absorbance was read at 700 nm (Unico 2100, Shangai, 
China) against ascorbic acid as authentic standard. Higher 
absorbance of the reaction mixture indicates higher 
reducing power. EC50 value (µg/mL) is the effective 
concentration of the extract at which the absorbance was 
0.5 and it was obtained from linear regression analysis. 
All samples were analyzed in triplicate.
Experimental animals
All the experimental procedures were carried out 
in accordance with international guidelines for care use 
of laboratory animals. Male Wistar rats (15 weeks old, 
weighing 200-230 g each) were purchased from Pasteur 
Institute of Tunis (Tunisia) and housed in stainless 
steel cages under controlled environmental conditions 
(temperature 22±1°C, relative air humidity of 45% to 
55% with a light/dark cycle of 12 hours). A commercial 
standard pellet diet (SNA, Borj Cedria, Tunisia) and water 
were given ad libitum.
Preparation of alloxan-induced diabetic rats
Induction of diabetes was carried out in rats by 
administering a single subcutaneous injection of 120 mg/
kg b.w. of a freshly prepared alloxan solution (alloxan 
monohydrate, Sigma Chemicals Co.), dissolved in acetate 
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buffer (pH 5.5) and prepared immediately before use. The 
control groups were injected only with the same volume 
of acetate buffer as the diabetic groups received. Alloxan 
induces diabetes through destructing Langerhans islands 
of the pancreas. Therefore, a large amount of insulin is 
released from the pancreas cells after the injection. In 
order to prevent hypoglycemic shock, during the first 
24 h after the alloxan injection, the rats received 10% 
dextrose instead of water (Rees, Alcolado, 2005; Kwon, 
Song, Choi, 2003). Induction of diabetes was confirmed 
by measuring fasting blood glucose (FBG) three days 
after alloxan injection. Rats with a blood glucose level 
of 250 mg/kg or higher were considered to be diabetic 
(Ghorbani et al., 2013).
Experimental design
Twenty-four rats were randomLy divided into four 
groups of six animals each as follows:
Group (NC): Normal control rats administered distilled 
water daily; 
Group (DC): Diabetic control rats administered distilled 
water daily; 
Group (CLE): Normal rats administered L. europaeum 
extract at 20 mg/kg b.w./day for 28 days (p.o.); 
Group (DLE): Diabetic rats administered L. europaeum 
extract at 20 mg/Kg b.w./day for 28 days (p.o.). 
During experiment, blood was collected from tip of 
the tail vein and fasting blood glucose level was measured 
once weekly by using a glucose analyzer. At the same 
time, the body weight of each rat was recorded. At the 
end of treatment (28th day), overnight fasted animals 
were scarified by decapitation under light anesthesia and 
blood was collected. Serum samples were obtained by 
centrifugation at 2200 g for 15 min and kept at -20 °C 
for the biochemical assay. The pancreas was removed 
from each rat, homogenized and analyzed for antioxidant 
enzymes.
Glucose levels and lipid profile 
Glucose, total cholesterol (TC), HDL-C, and 
triglyceride (TG) levels were assayed in serum collected 
at the end of the experiment and using commercial reagent 
kits purchased from Biomagreb Analyticals (Ariana 
Tunis, Tunisia). Glucose levels at J7, J14 and J21 were 
determined with glucometer. LDL-C was estimated by 
Friedwald method as follows:
LDL cholesterol = total cholesterol - HDL cholesterol - 
(Triglyceride ÷ 5)
All assessment assays and kits were performed 
in accordance with the manufacturer instructions and 
protocols.
Protein analysis in pancreas 
Protein concentration in pancreas tissue was 
determined according to Lowry et al. (1951), using bovine 
serum albumin as standard.
Pancreas homogenate preparation
Animals were euthanized by an over dose of 
diethyl ether and immediately dissected. The operation 
was handLed carefully to avoid pancreas damage. The 
pancreas was taken out, rinsed with saline pre-cooled to 
4 °C, the organ was dried with filter paper and weighed 
after removing adipose and connective tissue. Pancreas 
homogenates were centrifuged at 3000 rpm for 10 min 
at 4 °C and the supernatant was kept at -80 °C until use.
Antioxidant defense system assays 
The activities of three antioxidant enzymes: SOD, 
CAT and GPx were determined in pancreas homogenate 
and in serum. SOD activity was determined in pancreas 
homogenate according to the method of Beyer and 
Fridovich (1987). This method is based on the capacity 
of SOD to inhibit the oxidation of nitroblue tetrazolium 
(NBT). One unit of SOD represents the amount of 
enzymes required to inhibit the rate of NBT oxidation 
by 50% at 25°C.CAT activity was measured using the 
method of Aebi (1984). Hydrogen peroxide (H2O2) 
disappearance was monitored kinetically at 240 nm for 1 
min at 25 °C. The enzyme activity was calculated using 
an extinction coefficient of 0.043 Mm/cm. GPx activity 
was measured according to the method of Flohe and 
Gunzler (1984). GPx activity was quantified according 
to a coupled enzyme (GPx and glutathione reductase) 
procedure, which measures the decrease in absorbance at 
340 nm as NADPH is converted to NADP (Nicotinamide 
adenine dinucleotide phosphate). One unit of GPx 
activity was recorded as the quantity of enzyme oxidizing 
1 µmol NADPH per min
Statistical analysis 
The data were analyzed using the package Stat 
Graphics plus 5.1 (Stats graphics). Statistical analysis was 
performed using one-way analysis of variance (ANOVA) 
followed by Duncan’s test for comparison among groups. 
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All values were expressed as mean ± SE. Differences were 
considered significant if p<0.05.
RESULTS 
Total phenolic and flavonoid content of Lycium 
europaeum leaf extract 
Based on the absorbance values of the various 
extract solutions compared with the standard solution 
of gallic acid and catechin, total phenolic and flavonoid 
amounts were equal to 9.31±0.02 mg GAE/g DW and 
6.01±17 mg CE/g DW, respectively (Table I).
Antioxidant activities of Lycium europaeum leaf 
extract 
The antioxidant activity of boxthorn extract was 
explored using three different and complementary assays: 
total antioxidant capacity, DPPH free radical scavenging 
and reducing power (Table I). The antiradical activity 
evaluation of boxthorn aqueous extract displayed an IC50 
value equal to 200 µg/mL. Besides, our results showed 
a strong antioxidant capacity of L. europaeum leaves 
(17 mg GAE/g DW). The third antioxidant capacity was 
measured in terms of the iron reducing power, showing a 
lower EC50 value equal to 92 µg/mL and thus indicating a 
high reducing power activity.
Effect of Lycium europaeum on weight body
Changes in initial and final body weight in control 
and experimental groups are shown in Table II. Before 
the experiment start, no difference was observed between 
studied groups in terms of body weight. The alloxan-
induced diabetic rats exhibited a significant loss of the 
body weight as compared with control. However, boxthorn 
extract intake induced an increase in body weight in both 
control and diabetic rats.
Effect of Lycium europaeum on fasting blood 
glucose level 
As shown in Table II, the administration of alloxan 
(DC group) led to an elevation of fasting blood glucose 
levels, which reached a maximum of about 353.7 ± 30 mg/dL 
TABLE I - Total polyphenol, flavonoid contents and antioxidant capacity of Lycium europaeum extract
Total polyphenols 
(mg GAE/g)
Total flavonoids 
(mg CE/g)
Total antioxidant 
capacity 
(mg GAE/g)
DPPH 
(IC50, μg/mL)
Iron reducing 
power 
(EC50, μg/mL)
Leaf extract 9.31±0.02 6.01±0.17 17.24±0.83 200±0.05 92 ± 4
BHT - - - 24 ± 0.20 -
Ascorbic acid - - - - 42 ± 0.83
Total phenolic content was expressed by milligram gallic acid equivalent/gram; total flavonoid was expressed by milligram catechin 
equivalent/gram; total antioxidant capacity was expressed by milligram gallic acid equivalent/gram; EC50 value is the effective 
concentration at which the antioxidant activity was 50%; the absorbance was 0.5 for reducing power; 1,1-diphenyl-2-picrylhydrazyl 
(DPPH) radical was scavenged by 50%; The EC50 value was obtained by interpolation from linear regression analysis. BHT and 
ascorbic acid were used as positive controls; values are the means of 3 replicates ± SD.
TABLE II - Fasting blood glucose level (mg/dL) and body weight (g) after four weeks of administration of Lycium europaeum 
extract in normal and alloxan- diabetic rats
Fasting blood glucose (mg/dL) Body weight (g)
Initial day Week 1 Week 2 Week 3 Week 4 Initial day Week 1 Week 2 Week 3 Week 4
NC 86.4±3.6 a 88.6±2.5 a 86±2.4a 88±3.6a 88.6±4.8 a 214.2±10.7a 227.5±6.9a 239.3±8.1a 251±8.6a 264.3±10.2a
DC 344.4±35.0b 353.7±30.4b 308.5±14.5b 332.7±20.7b 342.2±23.9b 217.5 ±6.1a 200.3±6.8b 203.5±6.5b 196.7±5.1b 186.7±10.2b
CLE 85.6±3.6 a 87.6±3.5 a 85.5±4.5 a 84.4±3.3 a 85.4±7.3 a 205±11a 217.2±11c 227.5±9.3a 238.7±8.6a 249.5±8.3 c
DLE 337.2±29.8b 249.7±33.7c 208.5±25.6c 186.6±19.0c 171.0±18.7c 210.0±11.4a 211.8±13.2c 214.5±10c 216.0±8.9c 221.5±10.3 d
Data are expressed as mean ± SD of measurements from 6 rats. Groups are labelled as follows: Group NC: normal control, Group DC: diabetic control, 
Group CLE: Normal control fed with Lycium europaeum extract, Group DLE: Diabetic rats fed with Lycium europaeum extract. Different letters in the 
same raw indicate significant differences at P ≤ 0.05 as determined by Duncan’s multiple range tests.
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during the first week, and persisted up to four weeks during 
the experiment. L. europaeum leaf extract exhibited no 
effect on the blood glucose level in normal rats (NC vs. 
CLE groups) and an effective hypoglycemic effect started 
after one week of treatment in diabetic rats (DLE vs DC 
groups) and continued for four weeks to reach 49.3% at 
the end of experimental period.
 
Effect of Lycium europaeum on lipid profile
As shown in Figure 1, serum TG, TC and LDL-C 
levels were significantly increased (p<0.05) in diabetic 
groups (DC, DLE) in comparison with controls (NC, 
CLE); whereas HDL-C was significantly decreased 
(p<0.05) in the diabetic groups in comparison with 
controls. In fact, treatment with this plant for four 
weeks resulted in a reduction in TG, TC and LDL-C 
compared to untreated diabetic rats while serum HDL-C 
levels were significantly (p < 0.05) increased in treated 
diabetic rats. 
Antioxidant enzyme activities 
Table III shows the antioxidant enzyme activities, 
namely SOD, CAT and GPx, in the serum and pancreatic 
homogenate of all the rat groups. Significantly lower 
pancreatic SOD, CAT and GPx activities (p<0.05) were 
observed in diabetic rats. 
DISCUSSION
The alloxan-induced rat model was successfully 
established for the analysis of L. europaeum leaf extract-
mediated antidiabetic, antihyperlipidemic and antioxidant 
effects.
Polyphenols and flavonoids are the major 
contributors of antioxidant activities of the herbs; therefore, 
they were sought in the L. europaeum leaf extract. Results 
showed that the total polyphenol and flavonoid amounts 
that could be extracted from L. europaeum leaves were 
9.31 mg GAE/g DW and 6.01 mg CE/g DW, respectively. 
Rjeibi et al. (2017) showed higher content of polyphenols 
(15.70 mg GAE DW) and flavonoids (7.64 mg CE/g DW) 
in the aqueous leaf extract of L. europaeum. Dahech et al. 
(2013) showed that polyphenol and flavonoid contents of 
L. shawii fruit ranged from 75 to 377 mg GAE/g DW and 
from 2 to 11.60 mg CE/g DW, respectively. Similarly, the 
flavonoid content of cultivated L. barbarum leaves (16.65 
mg CE/g DW) was much higher than that of the wild L. 
barbarum leaves (7.55 CE/g DW) (Jing et al., 2009). 
These differences in results could be due to biotic (species, 
organ and physiological stage) and abiotic (environmental, 
handLing, and solvent extraction) factors, as previously 
shown by Ksouri et al. (2008). Also, the solubility of phenol 
compounds is governed by temperature. In this context, 
Yang et al. (2015) reported that the total polyphenol 
content of L. barbarum berries extracted with hot water 
FIGURE 1 - Comparative levels of serum triglycerides, cholesterol, HDL-CH and LDL-CH in different rat groups. Groups are 
labelled as follows: Group NC: normal control, Group DC: diabetic control, Group CLE: Normal control fed with Lycium europaeum 
extract, Group DLE: Diabetic rats treated fed with Lycium europaeum extract. Data are expressed as mean ± SD of measurements 
from 6 rats. Means not sharing common letters are significantly different among the groups at P ≤ 0.05 as determined by Duncan’s 
multiple range tests.
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was notably lower than that obtained otherwise (2.55 vs. 
5.32 %). Meanwhile, Yujing et al. (2017) indicated that 
the contents of bioactive compounds and the antioxidant 
activity of L. barbarum infusions increased with time and 
temperature. Otherwise, Gupta et al. (2011) reported that 
flavonoids act as insulin secretagogues or insulin-mimetics 
by influencing the pleiotropic mechanisms to attenuate 
diabetic complications. The presence of flavonoids in 
L. europaeum may be responsible for the stimulation of 
glucose uptake in peripheral tissues and regulation of the 
activity and/or expression of the rate-limiting enzymes 
involved in the metabolism of carbohydrates.
The antioxidant capacity of plant extracts is assayed 
through several techniques. Each method relates to the 
generation or use of a different radical directly involved 
in the oxidative process, acting through a variety of 
mechanisms. Hence, no single assay can measure total 
antioxidant capacity (Milella et al., 2014). In this study, 
the antioxidant activities of L. europaeum extract were 
analyzed using three different and complementary assays: 
DPPH free radical scavenging, total antioxidant capacity 
and iron reducing power. The DPPH radical scavenging 
assay evaluated the ability of plant extracts to scavenge 
free radicals generated from DPPH reagent (Chung et 
al., 2006). In fact, DPPH is a stable free radical; when an 
antioxidant reacts with DPPH, the electron is paired off 
and the DPPH solution is decolorized. The scavenging 
activity of the antioxidant or the bleaching of the color 
stochiometrically depends on the number of electrons 
taken up (Shirwaikar, Patel, Kamariya, 2011). The present 
work also involved the evaluation of the antiradical activity 
of aqueous L. europaeum extract (IC50 = 200 µg/mL) 
which was three fold higher than that obtained by Rjeibi 
et al. (2017) with IC50 = 65.87 µg/mL. It was observed 
that despite the inability of L. europaeum leaf extract to 
compete with the positive control BHT in scavenging 
DPPH (IC50 = 24 µg/mL), this extract did possess mild 
antioxidant activity and may be considered as a potential 
preservative for medical applications. Additionally, our 
results showed L. europaeum leaves to have a strong 
antioxidant capacity (17 mg GAE/g DW). This finding 
was consistent with Tawaha et al. (2007) who proved 
that the total antioxidant activity was remotely correlated 
to the content of flavonoids and polyphenols. The 
antioxidant activity of polyphenols is also due to their 
red-ox properties that make them act as reducing agents, 
hydrogen donors and singlet oxygen quenchers. The third 
antioxidant capacity was measured in terms of the iron 
reducing power. A low EC50 (92 µg/mL) was obtained, 
which indicated a higher reducing power activity. 
Antioxidants reducing the ferric ion/ferricyanide complex 
to the ferrous form of the extracts may provide a significant 
indication of the potential antioxidant capacity of the plant. 
The reducing properties are generally connected to the 
presence of reductones, which exert antioxidant activity 
by breaking the free radical chain through the donation 
of a hydrogen atom (Xing et al., 2005). Therefore, the 
potent antioxidant activity of L. europaeum leaves might 
be related to the presence of secondary metabolites 
such as polyphenols and flavonoids. In this way, Rjeibi 
et al. (2017) reported that the chemical composition of 
L. europaeum leaf extract was rich in phenolic acids, 
namely caffeic (140.18 µg/g), gallic (117.17 µg/g), 
vanillic (26.54 µg/g) and coumaric (1.38 µg/g) acids, and 
flavonoids, namely naringenin (57.18 µg/g), epicatechin 
(33.14 µg/g), rutin (25.16 µg/g), kaempferol (12.33 µg/g), 
TABLE III - Effect of Lycium europaeum extract and/or alloxan treatment on SOD, CAT and GPx activities in plasma and pancreatic 
homogenates of treated rats
Antioxidant enzymes
Pancreatic homogenate Plasma
SOD 
(U/mg protein)
CAT 
(Mol H
2
O
2
/min/
mg protein)
GPx 
(10-3 mM/min/
mg protein)
SOD 
(U/mL)
CAT 
(U/mL)
GPx 
(U/mL)
NC 26.4±3.5a 56.9±4.2a 2.9±0.6a 459.5±26.3 a 9.9±1.2a 637.5±37.2a
DC 10.8±1.4b 20.4±1.8b 0.8±0.2b 228.4±15.7b 3.9±0.9b 344.6±30.9b
CLE 28.9±3.6a 55.8±3.2a 2.6±0.5a 489.7±38.2 c 10.6±1.4a 695.7±58.2c
DLE 22.4±1.4a 38.9±3.8c 1.9±0.3c 358.8±63.7 d 8.8±1.0a 590.6±112.5d
Data are expressed as mean± SD of measurements from 6 rats. Groups are labeled as follows: Group NC: normal control, Group 
DC: diabetic control, Group CLE: normal control fed with Lycium europaeum extract, Group DLE: diabetic rats fed with Lycium 
europaeum extract. Different letters in the same raw indicate significant differences at P ≤ 0.05 as determined by Duncan’s multiple 
range tests.
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catechin (10.66 µg/g), luteolin (9.85 µg/g), apigenin 
(9.47 µg/g) and quercetin (1.53 µg/g).
In order to evaluate the capacity of L. europaeum 
leaf extract to cure diabetes, alloxan was used to induce 
hyperglycemia in rats. Alloxan has been recognized as a 
convenient experimental model to evaluate the activity 
of hypoglycemic agents (Ramkumar et al., 2009). It 
destroys the β-cells of islets in the pancreas Langerhans, 
resulting in a depletion of endogenous insulin secretion 
and leading to a decreased utilization of glucose by body 
tissues (Szkudelski, 2001). Obtained results showed 
that the administration of L. europaeum extract induces 
an increase in animal body weight in both control and 
diabetic rats. Additionally, L. europaeum leaf extract 
proved a potent hypoglycemic effect starting at one 
week of treatment in diabetic rats (DLE vs. DC groups) 
and continued for four weeks, reaching 49.3% at the 
end of the experimental period. Several studies in the 
last decades have shown that plant and plant-based 
therapies have a potential to control and treat diabetes 
and its complications (Marles, Farnsworth, 1995). The 
ability of this plant extract to reduce blood glucose level 
could be attributed to an improvement of the peripheral 
sensitivity to remnant insulin or to its capacity to induce 
stimulation of Langerhans islets. In fact, alloxan is known 
to induce free radical production and cause tissue injury. 
The pancreas is specifically susceptible to the action of 
alloxan-induced free radical damage. As reported by Akah, 
Uzodinma and Okolo (2011), the regeneration of islet 
β-cells after destruction by alloxan may be the primary 
recovery mechanism of alloxan-injected rats following 
plant extract administration. In addition, L. europaeum 
leaf extract was characterized by the presence of well-
known antioxidant phytochemicals, namely phenolic 
acids (caffeic, gallic, vanillic and coumaric acids) and 
flavonoids (naringenin, epicatechin, rutin, kaempferol, 
catechin, luteolin, apigenin and quercetin) as mentioned 
by Rjeibi et al. (2017). Several studies have mentioned the 
antidiabetic effect of caffeic acid (Jung et al., 2006), gallic 
acid (Adeniyi et al., 2015), coumaric acid (Amalan et al., 
2016), naringenin (Ortiz-Andrade et al., 2008), catechin 
(Liu et al., 2014), rutin (Ghorbani, 2017), kaempferol 
(Al-Numair et al., 2015), luteolin (Zang, Igarashi, Li, 
2016), apigenin (Cazarolli et al., 2012) and quercetin 
(Vessal, Hemmati, Vasei, 2003). These compounds 
influence glucose metabolism by several mechanisms, 
such as inhibition of carbohydrate digestion and glucose 
absorption in the intestine, stimulation of insulin secretion 
from the pancreatic β-cells, modulation of glucose release 
from the liver, activation of insulin receptors and glucose 
uptake in insulin-sensitive tissues and the modulation 
of hepatic glucose production (Hanhineva et al., 2010). 
Therefore, L. europaeum leaf extract could be prescribed 
as therapy for DM.
The chronic hyperglycemia of diabetes is associated 
with the long-term damage, dysfunction and failure of 
various organs, especially eyes, kidneys, nerves, heart 
and blood vessels (Baynes, 1991). DM is also related 
to a hyperlipidemia and leads to serious anomalies 
in lipid composition and concentration (Cooperstin, 
Watkin, 1981). Abnormal lipid metabolism leads 
to the accumulation of plasma TG, LDL and TC, as 
well as decreased HDL-C, commonly associated 
with diabetes (Kondeti et al., 2010). As reported by 
Betterridge (2002), the insulin deficiency or insulin 
resistance may be responsible for hyperlipidemia due 
to the insulin inhibiting action on the 3-hydroxy-3-
methyl-methylglutaryl coenzyme-A which is a key 
enzyme in cholesterol biosynthesis. Due to diabetes, 
the hyperlipidemia may be regarded as a result of the 
non-inhibiting action of lipolytic hormones on adipose 
tissues (Goodman, Gilman, 1985). Our results showed 
that serum TG, TC and LDL-C levels were significantly 
increased (p<0.05) in diabetic groups (DC, DLE) in 
comparison to controls (NC, CLE) whereas HDL-C 
was significantly decreased (p<0.05) in the diabetic 
groups in comparison to control groups. On the other 
hand, L. europaeum was also able to improve some 
lipid metabolites. In fact, treatment with this plant for 
four weeks resulted in reduced TG, TC and LDL-C 
levels compared to untreated diabetic rats while serum 
HDL-C levels were significantly (p < 0.05) increased 
in treated diabetic rats. This data demonstrates for the 
first time that, in addition to its hypoglycemic effect, L. 
europaeum leaf extract can significantly improve the 
imbalance in lipid metabolism. Moreover, the reduced 
TC and increased HDL-C levels following L. europaeum 
administration were noteworthy, according to Wang et 
al. (2010), who reported that most drugs used in the 
treatment of hypercholesterolaemia reduced both total 
and HDL-C levels. Additionally, the polyphenols and 
flavonoids of L. europaeum extract, which contribute 
to its antioxidant properties, may play a synergistic role 
in its hypolipidemic effect. As reviewed by Bahadoran, 
Mirmiran and Azizi (2013), polyphenols have powerful 
modulator effects on many aspects of metabolic, 
endocrine and cellular signaling transduction of adipose 
tissue. They also reported that some polyphenols such 
as catechins increase β oxidation in adipocytes and 
down-regulate the enzymes and genes involved in 
lipogenesis, including lipoprotein lipase, fatty acid 
synthase complex, peroxisome proliferators-activated 
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receptor γ, regulatory element-binding protein 1-c and 
fatty acid binding protein. To the best of our knowledge, 
this is the first report on the hypolipidemic effect of L. 
europaeum leaf extract. Thus, it is reasonable to conclude 
that L. europaeum leaf extract could modulate blood lipid 
abnormalities by acting as a potential hypolipidemic 
agent. 
Oxidative stress, due to increased free radical 
formation and reduced antioxidant status, is widely 
believed to be a key factor in the pathogenesis and 
progression of diabetes (Punithavathi et al., 2011). 
Available evidence strongly suggests that excessive free 
radicals, particularly reactive oxygen species (ROS) 
generated from hyperglycemia-induced glucose auto-
oxidation and protein glycosylation, play a critical role 
in diabetes (Masjedi, Gol, Dabiri, 2013). Reddy et al. 
(2005) showed a close relationship between the increase 
of free radicals, blood glucose and lipid peroxidation in 
the induction of diabetes. Increased lipid peroxidation 
damages membrane function by decreasing membrane 
fluidity and changing the activity of membrane-bound 
enzymes and receptors (Verma, Itankar, Arora, 2013). 
Enzymatic antioxidants, such as SOD, CAT and GPx, 
play a vital role in preventing oxidative damage to the 
cells. Because of the unbalanced oxidant/antioxidant 
system in DM and its involvement in the mechanism 
of various pathological complications, the effect of the 
aqueous leaf extract of L. europaeum on oxidative stress 
was investigated. Our results corroborated previous 
works that have demonstrated that an increased blood 
glucose level induces a depletion of the antioxidant 
system (Punitha, Manoharan, 2006; Vina et al., 2006; 
Shabeer, Srivastava, Singh, 2009). The enzyme activity 
reductions observed in the diabetic control group 
suggest their excessive utilization in attenuating free 
radicals generated during the metabolism of alloxan, 
as it was already reported in diabetic animals (Onyeka, 
Nwakanma, Bakare, 2013). L. europaeum extract 
prevented this decrease, especially for SOD activity 
in pancreatic homogenate and CAT activity in serum, 
which became comparable to normal control values. SOD 
scavenges the superoxide radicals by converting them 
to H2O2 and molecular oxygen. The observed decrease 
in SOD activity in diabetic control rats could result 
from inactivation by H2O2 or by glycosylation of the 
enzyme, which have been reported to occur in diabetes. 
Meanwhile, the increase in its activities is an indication 
of its ability to scavenge ROS, thus contributing to the 
protective effect against oxidative stress and preventing 
further damage to membrane lipids. Natural antioxidant 
agents fundamentally originate from plants in the form 
of secondary metabolites (Marjorie, 1996). The presence 
of different types of bioactive components, like phenolic 
acids and flavonoids in L. europaeum extract, could 
be responsible for the antidiabetic activities (Sharma, 
2012) since they could scavenge free radicals, quench 
electronically excited compounds, reduce hydro-
peroxide formation, and attenuate production of ROS 
through the modulation of several pro-oxidant enzymes 
involved in the development of ROS, including xanthine 
oxidase, cyclooxygenase, lipoxygenase, microsomal 
monooxygenase, NADH oxidase and mitochondrial 
succinoxidase (Dembinska-Kiec et al., 2008). In fact, 
these bioactive components decreased lipid peroxidation 
and increased plasma total antioxidant capacity; they 
also attenuated stress-sensitive signaling pathways, 
pro-oxidant enzymes, and inducted antioxidant enzymes 
including SOD, CAT and GPx (Crespy, Williamson, 
2004). Thus, the antidiabetic effect of L. europaeum 
extracts might be due to these bioactive constituents.
CONCLUSION 
Currently, medical prevention and treatment of 
diabetic complications are mainly based on the optimized 
control of blood glucose. According to our findings, L. 
europaeum leaf extract has beneficial effects on blood 
glucose in diabetic rats, thus revealing its antidiabetic 
potential. L. europaeum extract was also able to restore 
altered levels of serum lipids and endogenous antioxidant 
enzymes revealing its antihyperlipidemic and antioxidant 
potential. These putative effects may be due to the additive 
effects of bioactive constituents present in the aqueous 
extract. Moreover, the consumption of L. europaeum 
leaf extract could be considered a good complementary 
source of natural antioxidant and as an adjunct therapy 
in the management of diabetes. However, intensive 
investigations must be conducted on the extract fractions 
to identify pharmacological active compound(s), to 
establish the possible mechanism(s) of action and to set 
appropriate doses.
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